SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-060967
Filing Date
2021-05-04
Accepted
2021-05-04 16:07:05
Documents
14
Period of Report
2021-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2115076d2_8k.htm   iXBRL 8-K 27839
2 EXHIBIT 99.1 tm2115076d2_ex99-1.htm EX-99.1 47713
6 GRAPHIC tm2115076d2_ex99-1img001.jpg GRAPHIC 19411
  Complete submission text file 0001104659-21-060967.txt   289766

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ptgx-20210504.xsd EX-101.SCH 3208
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptgx-20210504_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptgx-20210504_pre.xml EX-101.PRE 22725
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2115076d2_8k_htm.xml XML 3858
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37852 | Film No.: 21888442
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences